Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal Study

3 Aug 2023

Abstract excerpt

Cervical intraepithelial neoplasia (CIN) grade 2/3 has a high spontaneous regression rate, especially among women ≤29 years of age. To reduce overtreatment, reliable prognostic biomarkers would be helpful. The main aim of this study was to analyze the negative predictive value of the methylation marker panel GynTect® for lesion regression. In this prospective, multicenter, longitudinal observational...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related molecular mechanisms research
Share to Cervical Cancer and HPV Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37568767
DOI: 10.3390/cancers15153951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of CIN2/3 Lesion Regression in GynTect® DNA Methylation-Marker-Negative Patients in a Longitudinal StudyPMID 37568767Read ↗

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of FAM19A4/miR124-2 DNA Methylation (CONCERVE Study).Semantic proximity Read ↗

Tissue-based methylation testing as a predictor of clinical regression in patients with high- grade cervical intraepithelial neoplasia (CIN2/3)Semantic proximity Read ↗

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity Read ↗

Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening ProgramSemantic proximity Read ↗

Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.Semantic proximity Read ↗

Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial NeoplasiaSemantic proximity Read ↗

Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study.Semantic proximity Read ↗

Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programmeSemantic proximity Read ↗

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3Semantic proximity Read ↗

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.Semantic proximity Read ↗

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.Semantic proximity Read ↗

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.